Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Magnesium Sulfate in ESPB for Scoliosis Surgery
NCT05671081Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine and magnesium sulfate in postoperative pain (3 arms), sponsored by Ain Shams University. Primary endpoint: First time to analgesic requirement at 48 hours. Started Jan 2023; status: completed.
02
Drugs
dexmedetomidinemagnesium sulfate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05671081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05671081.